Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Extended-release oxycodone1件: Oxycodone3件: D03783 (Name: Oxycodone terephthalate),
D05312 (Name: Oxycodone),
D05462 (Name: Oxycodone hydrochloride hydrate)		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 13
2OXYCODO----1件: 6
3Oxycodone1件: Oxycodone3件: D03783 (Name: Oxycodone terephthalate),
D05312 (Name: Oxycodone),
D05462 (Name: Oxycodone hydrochloride hydrate)		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬7件: 6, 13, 46, 70, 226, 231, 298
4Oxycodone by patient-controlled analgesia (PCA)1件: Oxycodone3件: D03783 (Name: Oxycodone terephthalate),
D05312 (Name: Oxycodone),
D05462 (Name: Oxycodone hydrochloride hydrate)		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 46
5Oxycodone Depot ”Sandoz”, depot tablets1件: Oxycodone3件: D03783 (Name: Oxycodone terephthalate),
D05312 (Name: Oxycodone),
D05462 (Name: Oxycodone hydrochloride hydrate)		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 298
6OXYCODONE HYDROCHLORIDE1件: Oxycodone3件: D03783 (Name: Oxycodone terephthalate),
D05312 (Name: Oxycodone),
D05462 (Name: Oxycodone hydrochloride hydrate)		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬4件: 6, 70, 226, 298
7Oxycodone naloxone prolonged release tablets2件: Naloxone,
Oxycodone		5件: D01340 ,
D03783 (Name: Oxycodone terephthalate),
D05312 (Name: Oxycodone),
D05462 (Name: Oxycodone hydrochloride hydrate),
D08249 		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226
8Oxycodone Orion1件: Oxycodone3件: D03783 (Name: Oxycodone terephthalate),
D05312 (Name: Oxycodone),
D05462 (Name: Oxycodone hydrochloride hydrate)		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 70
9Oxycodone/Acetaminophen2件: Acetaminophen (Synonym: Oxycodone/APAP),
Oxycodone		4件: D00217 ,
D03783 (Name: Oxycodone terephthalate),
D05312 (Name: Oxycodone),
D05462 (Name: Oxycodone hydrochloride hydrate)		5件: OPRD1,
OPRK1,
OPRM1,
PTGS1,
PTGS2 💬		28件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Estrogen signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, Morphine addiction, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, Sphingolipid signaling pathway, TNF signaling pathway, VEGF signaling pathway, cGMP-PKG signaling pathway 💬1件: 231
10Oxycodone/naloxone prolonged release t3件: Manganese citrate,
Naloxone,
Oxycodone		5件: D01340 ,
D03783 (Name: Oxycodone terephthalate),
D05312 (Name: Oxycodone),
D05462 (Name: Oxycodone hydrochloride hydrate),
D08249 		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226
11Oxycodone/Naloxone Prolonged Release tablets2件: Naloxone,
Oxycodone		5件: D01340 ,
D03783 (Name: Oxycodone terephthalate),
D05312 (Name: Oxycodone),
D05462 (Name: Oxycodone hydrochloride hydrate),
D08249 		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6
12Oxycodone/naloxone prolonged release tablets 10 mg /5 mg3件: Manganese citrate,
Naloxone,
Oxycodone		5件: D01340 ,
D03783 (Name: Oxycodone terephthalate),
D05312 (Name: Oxycodone),
D05462 (Name: Oxycodone hydrochloride hydrate),
D08249 		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6
13Oxycodone/naloxone prolonged release tablets 10/5 mg3件: Manganese citrate,
Naloxone,
Oxycodone		5件: D01340 ,
D03783 (Name: Oxycodone terephthalate),
D05312 (Name: Oxycodone),
D05462 (Name: Oxycodone hydrochloride hydrate),
D08249 		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226
14Oxycodone/naloxone prolonged release tablets 20 mg /10 mg3件: Manganese citrate,
Naloxone,
Oxycodone		5件: D01340 ,
D03783 (Name: Oxycodone terephthalate),
D05312 (Name: Oxycodone),
D05462 (Name: Oxycodone hydrochloride hydrate),
D08249 		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6
15Oxycodone/naloxone prolonged release tablets 20/10 mg3件: Manganese citrate,
Naloxone,
Oxycodone		5件: D01340 ,
D03783 (Name: Oxycodone terephthalate),
D05312 (Name: Oxycodone),
D05462 (Name: Oxycodone hydrochloride hydrate),
D08249 		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226
16Oxycodone/naloxone prolonged release tablets 5 mg /2.5 mg3件: Manganese citrate,
Naloxone,
Oxycodone		5件: D01340 ,
D03783 (Name: Oxycodone terephthalate),
D05312 (Name: Oxycodone),
D05462 (Name: Oxycodone hydrochloride hydrate),
D08249 		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6
17Oxycodone/naloxone prolonged release tablets 5/2.5 mg3件: Manganese citrate,
Naloxone,
Oxycodone		5件: D01340 ,
D03783 (Name: Oxycodone terephthalate),
D05312 (Name: Oxycodone),
D05462 (Name: Oxycodone hydrochloride hydrate),
D08249 		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226
18Oxycodonhydrochlorid ”Lannacher”, depot tablets----1件: 298
19PR Oxycodone1件: Oxycodone3件: D03783 (Name: Oxycodone terephthalate),
D05312 (Name: Oxycodone),
D05462 (Name: Oxycodone hydrochloride hydrate)		3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6